Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-01-31
2006-01-31
Solola, Taofiq (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C548S530000, C548S531000, C548S538000
Reexamination Certificate
active
06992102
ABSTRACT:
The invention provides compounds of the formula Iwherein the substitutents are as described herein.Further provided are methods of using such compounds for the treatment of nuclear hormone receptor-associated conditions, such as age related diseases, for example sarcopenia, and also provided are pharmaceutical compositions containing such compounds.
REFERENCES:
patent: 3948933 (1976-04-01), Fontanella
patent: 5403817 (1995-04-01), Seckinger et al.
patent: 5482921 (1996-01-01), Seckinger et al.
patent: 5605877 (1997-02-01), Schafer et al.
patent: 2002/0058685 (2002-05-01), Hamilton
patent: A-82875/87 (1988-06-01), None
patent: 0 272 594 (1987-12-01), None
patent: 0 493323 (1992-01-01), None
patent: 1 004 583 (2000-05-01), None
patent: 1 503 244 (1978-03-01), None
patent: WO 00/13508 (2000-03-01), None
patent: WO 01/16108 (2001-03-01), None
patent: WO 01/16133 (2001-03-01), None
patent: WO 01/16139 (2001-03-01), None
patent: WO 01/30781 (2001-05-01), None
patent: WO 01/46195 (2001-06-01), None
Alexey B. Dyatkin, (1997) Tetrahedron Letters, vol. 28, No. 12, pp. 2065-2066.
I. Lalezari (1), S. Seifter and A. Thein (2), “Synthesis of 1H,3H-Imidazo[1,5-c]thiazole-5,7-[6H,7aH]-dione and 7,8-Dihydro-5H-imidazo[1,5-c][1,3]thiazine-1,3-[2H,8aH]-dione and Derivatives”, Journal of Heterocyclic Chemistry, 20(2), pp. 483-485 (1983).
Uozumi, Y. et al., “A parallel preparation of a bicyclicN-chiral amine library and its use for chiral catalyst screening”, Tetrahedron Letters 42, pp. 407-410 (2001).
Iseki, K. et al., “Asymmetric Allylation of Aromatic Aldehydes Catalyzed by Chiral Phosphoramides Prepared from (S)-Proline”, Tetrahedron, vol. 53, No. 10, pp. 3513-3526 (1997).
Augeri David
Hamann Lawrence
Robl Jeffrey A.
Salvati Mark E.
Sun Chongqing
Bristol--Myers Squibb Company
Duncan, Jr. Sammy G.
O'Brien Maureen P.
Shiao Robert
Solola Taofiq
LandOfFree
Bicyclic modulators of androgen receptor function does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Bicyclic modulators of androgen receptor function, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Bicyclic modulators of androgen receptor function will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3595288